Home Alimera Sciences: Insiders Buying This Biotech, Stock Sees Catalyst
 

Keywords :   


Alimera Sciences: Insiders Buying This Biotech, Stock Sees Catalyst

2015-10-13 08:51:01| Biotech - Topix.net

Alimera Sciences is a bio-pharmaceutical company on the Nasdaq with a market cap of $116 million. The company has developed a product called Iluvien , which was FDA approved in 2014 and made commercially available in the US, UK, Germany and Portugal.

Tags: stock buying sciences sees

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
More »